Note: Alexis Bio's revenues are gauged from an analysis of company filings.
Alexis Bio's Income Statement (based on Industry Averages)
Alexis Bio P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Alexis Bio has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
April 6, 2021
0
N/A
$0 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Alexis Bio is developing and marketing.
Alexis Bio doesn't have any recent trademark applications, indicating Alexis Bio is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
XENO-BIOLOGICS Scientific and technological services and research relating thereto, namely, scientific research and development, product research and development, design and testing for new product development in the field of xenotransplantation, xenotransplantation products, biologics, and genetic engineering of animal genomes
11/27/2019
XENO-GENOMICS Scientific and technological services and research relating thereto, namely, scientific research and development, product research and development, design and testing for new product development in the field of xenotransplantation, xenotransplantation products, biologics, and genetic engineering of animal genomes
11/27/2019
XENOTHERAPEUTICS Research in the field of xeno-transplantation; Biotechnology research; Scientific research
12/02/2016
See all trademarks and details in the Full Report.
Market Share of Alexis Bio's Largest Competitors
A competitive analysis shows these companies are in the same general field as Alexis Bio, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Alexis Bio.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Alexis Bio and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.